Next-Generation Anti-IL-17 Agents for Psoriatic Disease: A Pipeline Review: Anti-IL-17 Agents for Psoriatic Disease Pipeline
1. 系统已在2026-08-14 16:40:47对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
D Kim, S Yang, M Gill, N Babaei, M Cervantes…
American Journal of …, 2025
Springer
… , S‑011806) and DC‑853 (LY‑4100511) DC-806 and DC-853 are both orally administered
small molecule IL-17 inhibitors. DC-806 is the lead candidate, while DC-853 is a fast-follower …

